Synthomer maintains significant financial leverage as part of its ongoing industrial turnaround strategy, with net debt to EBITDA metrics fluctuating near elevated covenant levels around 4.9x. The specialty chemical enterprise remains intensely focused on asset divestments, working capital management, and structural cost reductions to accelerate net debt repayment and improve its financial stability across macroeconomic industrial downturns.